Hogan Lovells Publications
Clarifying clinical decision support: FDA overhauls guidance to focus on risk Medical Device Alert
03 October 2019
Senior AssociateWashington, D.C.
Email suzanne.friedman@hoganlovells.com
Phone +1 202 637 5532
Fax +1 202 637 5910
LanguagesEnglish, French, Spanish, Hebrew
Practice groupGlobal Regulatory
Global clients in the medical device sector call on Suzanne Levy Friedman to help them navigate key legal and business issues. Suzanne's practice focuses primarily on matters related to the U.S. Food and Drug Administration's (FDA) regulation of medical devices.
Suzanne assists device companies in a wide range of activities across the life cycle of their products, including preparing regulatory submissions for clearance or approval of new devices, advising manufacturers on the lawful promotion and advertising of their devices, and addressing postmarket enforcement issues. Suzanne is well-versed regarding FDA's evolving paradigm for software and digital health products, and she has helped clients determine the appropriate regulatory pathway for various products in this space and bring them to market. She also conducts regulatory due diligence in preparation for mergers and acquisitions.
Suzanne frequently works on human tissue and combination products that combine a medical device element with a drug or a biologic. In conjunction, she helps advise clients on regenerative medicine and cell/gene therapies, which often raise questions that touch on multiple areas of FDA regulation.
Suzanne brings significant experience in FDA space to her work at the firm. During law school, she interned for FDA's Office of Chief Counsel, where she learned firsthand about the range of legal and regulatory issues addressed by the agency's Food, Drug, Device, Veterinary, and Tobacco centers. Prior to law school, Suzanne spent two years with a health policy consulting firm in Washington, D.C., advising clients on the business impacts of FDA actions and related legislation. Suzanne also has a master's degree in bioethics.
In law school, Suzanne co-led Penn Law's health law and policy pro bono group, and she remains actively involved in pro bono service at Hogan Lovells.
Education
J.D., University of Pennsylvania Law School, 2014
M. Bioethics, University of Pennsylvania School of Medicine, 2014
B.A., Princeton University, cum laude, 2008
Bar admissions and qualifications
District of Columbia
New York
Advised companies with various types of medical devices on balancing FDA rules for device promotion with business needs in developing their websites and marketing materials.
Drafted legal arguments for premarket clearance of various innovative medical devices.
Conducted comprehensive audit of device and manufacturing process modifications for PMA-approved device and helped client properly notify FDA and obtain approval for same.
Advocated to obtain client's desired outcome to have its wound dressing classified solely as a medical device rather than a combination product.
Helped a woman (political dissident) from the Democratic Republic of Congo obtain asylum in the United States.
Assisted an international client with drafting a PMA for its device and ensuring a successful pre-approval FDA inspection.
Hogan Lovells Publications
03 October 2019
Sponsorships and Speaking Engagements
24 September 2019
Hogan Lovells Publications
12 April 2019
Hogan Lovells Publications
05 April 2019
Hogan Lovells Publications
12 December 2018
Hogan Lovells Publications
10 October 2018